These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 915501

  • 21. Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: evidence for both pre- and post-synaptic inhibition of catecholamine systems.
    Cott J, Engel J.
    J Neural Transm; 1977; 40(4):253-68. PubMed ID: 18553
    [Abstract] [Full Text] [Related]

  • 22. Antipsychotic drugs and catecholamine synapses. Summary of the session.
    Andén NE.
    J Psychiatr Res; 1974; 11():97-104. PubMed ID: 4156797
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of metoclopramide on turnover of brain dopamine noradrenaline and 5-hydroxytryptamine.
    Peringer E, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1975 Jun; 27(6):442-4. PubMed ID: 237096
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.
    Menon MK, Clark WG, Masuoka DT.
    Psychopharmacology (Berl); 1977 May 09; 52(3):291-7. PubMed ID: 406633
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antipsychotic drugs, neurotransmitters, and schizophrenia.
    Carlsson A.
    Am J Psychiatry; 1978 Feb 09; 135(2):165-73. PubMed ID: 23684
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.
    Fuxe K, Fredholm BB, Agnati LF, Ogren SO, Everitt BJ, Jonsson G, Gustafsson JA.
    Pharmacology; 1978 Feb 09; 16 Suppl 1():99-134. PubMed ID: 643908
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC, Jenner P, Marsden CD.
    Pharmacol Biochem Behav; 1976 Jun 09; 4(6):661-70. PubMed ID: 981283
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of chronic clonidine treatment on the turnover of noradrenaline and dopamine in various regions of the rat brain.
    Rochette L, Bralet AM, Bralet J.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr 09; 319(1):40-2. PubMed ID: 7110369
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The effect of diphenylhydantoin on central catecholamine containing neuronal systems.
    Elliott PN, Jenner P, Chadwick D, Reynolds E, Marsden CD.
    J Pharm Pharmacol; 1977 Jan 09; 29(1):41-3. PubMed ID: 13181
    [No Abstract] [Full Text] [Related]

  • 40. Theophylline increased sensitivity to nociceptive stimulation and regional turnover of rat brain 5-HT, noradrenaline and dopamine.
    Paalzow G, Paalzow L.
    Acta Pharmacol Toxicol (Copenh); 1974 Mar 09; 34(3):157-73. PubMed ID: 4406320
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.